"Dadka lagu tallaalay Pfizer waxay u badan tahay inay u baahan doonaan qiyaas seddexaad laba iyo toban bilood gudahood si ay u helaan difaac buuxa," maamulaha Albert Bourla ayaa u sheegay CNBC.
Waxa uu sidoo kale sheegay in ay suurtagal tahay in dadku ay u baahan doonaan in laga tallaalo fayraska sannadkii.
Shirkadda ayaa soo warineysa horaantii bishaan in daraasado dhowaan la sameeyay ay muujinayaan in tallaalku wali saameyn wanaagsan leeyahay lix bilood ka dib. Daraasada ayaa lagu sameeyay 12 oo qof.
Si kastaba ha ahaatee, daraasado cusub ayaa loo baahan yahay si loo eego haddii tallaalku sidoo kale bixiyo difaac waqtigan ka dib.
2 qiyaasood ayaa ku filan
"Waxaan u aragnaa dadka in si buuxda loo tallaalo marka ay helaan 2 qiyaasood oo tallaalka BioNTech/Pfizer," ayay tiri madaxa caafimaadka Sara Viksmoen Watle ee FHI.
Waxay xustay in tijaabooyinka bukaan-socod ee oggolaanshaha kahor ay muujiyeen ilaalin heersare ah oo ka dhan ah COVID-19, iyo daraasado dabagal ah, oo ay ku jiraan Israa'iil, ayaa xaqiijinaya natiijooyinkan.
– Waxa kale oo jira daraasado laga sameeyay Boqortooyada Midowday (UK) oo muujinaya ka-hortagga wanaagsan ee cudurrada halista ah ee dadka da'da ah ka dib qiyaasta koowaad. Daraasado laga sameeyay waddamo dhowr ah ayaa sidoo kale tilmaamaya in uu jiro difaac wanaagsan oo ka hortagga caabuqa, labadaba calaamadaha leh iyo kuwa aan lahayn, ka dib labadaba qiyaasta koowaad iyo labaad.
- Qiyaasta suurtagalka ah ee nasinta
Wiksmoen Vatle waxay aaminsan tahay in hadalka Pfizer uu muujinayo in laga yaabo inay ku habboon tahay mustaqbalka fog in la siiyo qiyaas dib-u-cusboonaysiin ah dadka hore si buuxda loo tallaalay, maadaama ay xasaanaddaadu daciifi doonto waqti ka dib.
- Marka tani ay noqon doonto mid muhiim ah, waa goor hore in la sheego hadda, laakiin daraasado ayaa socda si loo baaro halka jawaabta difaacu ay sii socoto iyo sida wanaagsan ee saameynta loo gaaro ka dib markii la qaato qiyaasta saddexaad ee isla tallaalka ama mid si aad ah loogu beegsanayo kuwa cusub kala duwanaanshaha fayraska.